The Interaction of Myc with Miz1 Defines Medulloblastoma Subgroup Identity

Cancer Cell
BaoHan T VoMartine F Roussel

Abstract

Four distinct subgroups of cerebellar medulloblastomas (MBs) differ in their histopathology, molecular profiles, and prognosis. c-Myc (Myc) or MycN overexpression in granule neuron progenitors (GNPs) induces Group 3 (G3) or Sonic Hedgehog (SHH) MBs, respectively. Differences in Myc and MycN transcriptional profiles depend, in part, on their interaction with Miz1, which binds strongly to Myc but not MycN, to target sites on chromatin. Myc suppresses ciliogenesis and reprograms the transcriptome of SHH-dependent GNPs through Miz1-dependent gene repression to maintain stemness. Genetic disruption of the Myc/Miz1 interaction inhibited G3 MB development. Target genes of Myc/Miz1 are repressed in human G3 MBs but not in other subgroups. Therefore, the Myc/Miz1 interaction is a defining hallmark of G3 MB development.

References

Oct 6, 1997·The EMBO Journal·K PeukertM Eilers
Apr 3, 2001·Nature Cell Biology·P StallerM Eilers
Apr 3, 2001·Nature Cell Biology·J SeoaneJ Massagué
Oct 16, 2003·Molecular and Cellular Biology·Sovana AdhikaryMartin Eilers
Oct 18, 2005·Cancer Cell·Michael D TaylorRichard J Gilbertson
Jul 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·Frederique ZindyMartine F Roussel
Aug 25, 2009·Nature Medicine·Young-Goo HanArturo Alvarez-Buylla
Apr 17, 2010·Nature Reviews. Genetics·Sarah C Goetz, Kathryn V Anderson
Jan 14, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Somasish Ghosh DastidarSantosh R D'Mello
Dec 3, 2011·Acta Neuropathologica·Michael D TaylorStefan M Pfister
Feb 22, 2012·Cancer Cell·Yanxin PeiRobert J Wechsler-Reya
Feb 22, 2012·Cancer Cell·Daisuke KawauchiMartine F Roussel
Apr 3, 2012·Cell·Chi V Dang
Oct 4, 2013·Nature Communications·Elmar WolfMartin Eilers
Nov 5, 2013·Cold Spring Harbor Perspectives in Medicine·Martine F Roussel, Giles W Robinson
Jan 5, 2014·Cold Spring Harbor Perspectives in Medicine·Maralice Conacci-SorrellRobert N Eisenman
Oct 29, 2014·Nature Reviews. Clinical Oncology·Amar J Gajjar, Giles W Robinson

❮ Previous
Next ❯

Citations

Jan 15, 2016·Cancer Cell·Haritha Mathsyaraja, Robert N Eisenman
Mar 24, 2017·Genes·Sonja HutterFredrik J Swartling
Jul 25, 2017·Cell Cycle·Johannes BrägelmannMartin L Sos
Dec 1, 2017·International Journal of Molecular Sciences·Juwina WijayaJohn D Schuetz
Oct 4, 2018·Medical Sciences : Open Access Journal·Ugo TestaElvira Pelosi
Jul 29, 2018·Frontiers of Medicine·Patrick A CarrollRobert N Eisenman
Jan 27, 2019·Nature Communications·Xia ShengFahri Saatcioglu
Mar 17, 2019·Journal of Hematology & Oncology·Otília MenyhártBalázs Győrffy
Feb 20, 2020·Nature Reviews. Molecular Cell Biology·Apoorva BaluapuriMartin Eilers
Sep 7, 2016·Cellular and Molecular Life Sciences : CMLS·Jerry Vriend, Hassan Marzban
Sep 29, 2018·Journal of Experimental & Clinical Cancer Research : CR·Matteo CaforioValentina Folgiero
Jan 24, 2018·Cancer Discovery·David S RickmanMartin Eilers
Jan 11, 2021·Trends in Pharmacological Sciences·Dexter Kai Hao ThngEdward Kai-Hua Chow
Feb 16, 2021·Frontiers in Oncology·Anna BorgenvikFredrik J Swartling
Oct 24, 2020·International Journal of Molecular Sciences·Olga ZaytsevaLeonie M Quinn
Feb 23, 2021·Frontiers in Oncology·Ruochen LiuHongjuan Cui

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

© 2022 Meta ULC. All rights reserved